Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila). 2009 Nov; 2(11):931-41.